Myovant Z Score
MYOV   USA Stock  USD 20.28 0.22 1.07% 
Myovant Z Score Analysis
Myovant Sciences' ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..2018  2019  2020  2021 (projected)  
Current Assets  166.79 M  87.91 M  704.64 M  760.27 M 
Total Assets  172.98 M  105.93 M  725.03 M  782.27 M 
Z Score  =  Sum Of   5 Factors 
Current Myovant Sciences Z Score  7.3 
Most of Myovant Sciences' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Myovant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

Myovant Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Myovant Sciences is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Myovant Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Myovant Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Myovant Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
Based on the company's disclosures, Myovant Sciences has a Z Score of 7.3. This is 208.15% lower than that of the Healthcare sector and notably lower than that of the Biotechnology industry. The z score for all United States stocks is 183.72% higher than that of the company.
Myovant Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Myovant Sciences' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Myovant Sciences could also be used in its relative valuation, which is a method of valuing Myovant Sciences by comparing valuation metrics of similar companies.Myovant Sciences is currently under evaluation in z score category among related companies.
Myovant Fundamentals
Return On Equity  20.67 %  
Return On Asset  (35.36) %  
Operating Margin  (396.32) %  
Current Valuation  1.66 B  
Shares Outstanding  91.48 M  
Shares Owned by Insiders  60.22 %  
Shares Owned by Institutions  38.55 %  
Number of Shares Shorted  3.03 M  
Price to Earning  (8.56) X  
Price to Book  6.43 X  
Price to Sales  31.28 X  
Revenue  59.32 M  
Gross Profit  (79.36 M)  
EBITDA  (232.6 M)  
Net Income  (255.13 M)  
Cash and Equivalents  684.93 M  
Cash per Share  7.49 X  
Total Debt  369.7 M  
Debt to Equity  138.60 %  
Current Ratio  2.51 X  
Book Value Per Share  (3.89) X  
Cash Flow from Operations  370.63 M  
Short Ratio  4.19 X  
Earnings Per Share  (2.83) X  
Number of Employees  407  
Beta  2.86  
Market Capitalization  1.86 B  
Total Asset  151.84 M  
Retained Earnings  (811.83 M)  
Working Capital  123.03 M  
Current Asset  150.17 M  
Current Liabilities  27.14 M  
Z Score  7.3 
About Myovant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Myovant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myovant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myovant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Myovant Sciences Ltd., a clinicalstage biopharmaceutical company, focuses on developing and commercializing therapies for womens health and endocrine diseases. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 407 people.
Myovant Sciences Investors Sentiment
The influence of Myovant Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decisionmaking process regarding taking a position in Myovant. The overall investor sentiment generally increases the direction of a stock movement in a oneyear investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Myovant Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additionally, see Myovant Sciences Piotroski F Score and Myovant Sciences Valuation analysis. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Myovant Stock analysis
When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Equity ValuationCheck real value of public entities based on technical and fundamental data  Go  
Watchlist OptimizationOptimize watchlists to build efficient portfolio or rebalance existing positions based on meanvariance optimization algorithm  Go  
Focused OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences  Go  
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon  Go  
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins  Go  
Portfolio File ImportQuickly import all of your thirdparty portfolios from your local drive in csv format  Go  
Global CorrelationsFind global opportunities by holding instruments from different markets  Go  
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency  Go  
Fundamental AnalysisView fundamental data based on most recent published financial statements  Go  
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators  Go  
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and riskadjusted market performance  Go 
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.